Skip to main content
OpenTrials

Clinical trial condition

Carcinoid Tumor

Explore clinical trials studying Carcinoid Tumor. Study availability and eligibility vary by location and protocol.

67 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Carcinoid Tumor trial results

Completed

Post-Authorization Safety Study (PASS) of LysaKare® in Adult Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients

NCT04524442

Conditions
Adenocarcinoma, Carcinoid Tumor, Carcinoma, +9 more
Locations
  • Istituto Europeo di Oncologia Milan, MI, Italy
  • Erasmus University Medical Center Rotterdam, Gelderland, Netherlands
  • Gammed-Centrum Diagnostyczno-Lecznicze Warsaw, Poland
  • University Hospitals Birmingham NHS Foundation Trust Birmingham, United Kingdom
View Trial Details
Completed

A Multi-Center, Open-Label Study of Surufatinib (HMPL-012) in Patients With Advanced Solid Tumors

NCT02549937

Conditions
Adenocarcinoma, Carcinoid Tumor, Carcinoma, +12 more
Locations
  • City of Hope Comprehensive Cancer Center Los Angeles, California, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • SCRI at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View Trial Details
Completed

Carfilzomib for the Treatment of Patients With Advanced Neuroendocrine Cancers

NCT02318784

Conditions
Adenocarcinoma, Carcinoid Tumor, Carcinoma, +9 more
Locations
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Florida Hospital Cancer Institute Orlando, Florida, United States
  • Florida Cancer Specialists - North St. Petersburg, Florida, United States
View Trial Details

Related conditions